Lower Lactate Levels and Lower Intracellular pH in Patients with IDH -Mutant versus Wild-Type Gliomas von Wenger, K J, Steinbach, J P, Bähr, O, Pilatus, U, Hattingen, E

Volltext

Synthesis of cytochrome c oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell dea... von Wanka, C, Brucker, D P, Bähr, O, Ronellenfitsch, M, Weller, M, Steinbach, J P, Rieger, J

Volltext

Adult onset glutaric aciduria type I presenting with a leukoencephalopathy von BÄHR, O, MADER, I, ZSCHOCKE, J, DICHGANS, J, SCHULZ, J. B

Volltext

Complementary therapy use in patients with glioma: An observational study von HEESE, O, SCHMIDT, M, KREX, D, SCHACKERT, G, REITHMEIER, T, NIKKHAH, G, LÖFFLER, M, WELLER, M, WESTPHAL, M, NICKEL, S, BERGER, H, GOLDBRUNNER, R, TONN, J. C, BÄHR, O, STEINBACH, J. P, SIMON, M, SCHRAMM, J

Volltext

Attitudes and barriers associated with seasonal influenza vaccination uptake among public health students; a cross-sectional study von Rogers, Christopher J, Bahr, Kaitlin O, Benjamin, Stephanie M

Volltext

Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice von NAUMANN, U, BÄHR, O, WOLBURG, H, ALTENBEREND, S, WICK, W, LISTON, P, ASHKENAZI, A, WELLER, M

Volltext

P14.20 Quality of life of patients with newly diagnosed glioblastoma during TTFields therapy in routine clinical care: first results of the TIGER study von Bähr, O, Tabatabai, G, Fietkau, R, Goldbrunner, R, Glas, M

Volltext

"We are still tired": staff and administrators' experiences during the COVID-19 pandemic within California residential care facilities for older adults von Bahr, Kaitlin O, Bhavsar, Grishma P, Zhao, David

Volltext

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial von Wick, Wolfgang, Prof, Platten, Michael, Prof, Meisner, Christoph, PhD, Felsberg, Jörg, MD, Tabatabai, Ghazaleh, MD, Simon, Matthias, MD, Nikkhah, Guido, Prof, Papsdorf, Kirsten, MD, Steinbach, Joachim P, Prof, Sabel, Michael, MD, Combs, Stephanie E, MD, Vesper, Jan, MD, Braun, Christian, MD, Meixensberger, Jürgen, Prof, Ketter, Ralf, MD, Mayer-Steinacker, Regine, MD, Reifenberger, Guido, Prof, Weller, Michael, Prof

Volltext

Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival von Hattingen, Elke, Jurcoane, Alina, Daneshvar, Keivan, Pilatus, Ulrich, Mittelbronn, Michel, Steinbach, Joachim P, Bähr, Oliver

Volltext

P05.83 Tumor Treating Fields and radiosurgery for supra- and/or infratentorial brain metastases (1–10) from NSCLC in the phase 3 METIS study von Bähr, O, Mehta, M, Gondi, V, Ahluwalia, M, Brown, P

Volltext

P01.111 Using the ASCO and ESMO frameworks to assess the clinical value of tumor treating fields for newly diagnosed Glioblastoma multiforme von Proescholdt, C, Kelly, J, Kinzel, A, Bähr, O

Volltext

P01.095 The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER: TTFields in Germany in routine clinical care) von Bähr, O, Tabatabai, G, Fietkau, R, Goldbrunner, R, Glas, M

Volltext

Modulation of MDR/MRP by wild-type and mutant p53 von Bähr, O, Wick, W, Weller, M

Volltext

P14.63 The use of TTFields for newly diagnosed GBM patients in Germany in routine clinical care (TIGER: TTFields in Germany in routine clinical care) von Bähr, O, Tabatabai, G, Fietkau, R, Goldbrunner, R, Glas, M G

Volltext

P07.06 Does IDH1 R132H Mutation alter phospholipid metabolism in glioma? A 31 P-MRS in vivo study von Wenger-Alakmeh, K. J., Pilatus, U., Bähr, O. R.

Volltext

Barriers Associated with Seasonal Influenza Vaccination among College Students von Benjamin, Stephanie M., Bahr, Kaitlin O.

Volltext

P01.101 Treatment and survival of patients with lower grade glioma according to the 2007 and the 2016 WHO classification: A retrospective analysis of 423 patients von Steidl, E, Zeiner, P, Wagner, M, Fokas, E, Forster, M, Ronellenfitsch, M, Steinbach, J P, Harter, P N, Bähr, O

Volltext

Safety, efficacy, PK and PD biomarker results of the first-in-human study of mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor BAY 1436032 in patients (pts) with mIDH1 advanced s... von Wick, W., Tabatabai, G., Schuler, M., Rorhberg, K., Chawla, S.P., Janku, F., Schiff, D., Heinemann, V., Narita, Y., Ando, Y., Lenz, H.J., Ikeda, M., Genvresse, I., Rentzsch, C., Reschke, S., Cyris, C., Cai, C., Jeffers, M., Peña, C., Bähr, O.

Volltext

458P - Safety, efficacy, PK and PD biomarker results of the first-in-human study of mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor BAY 1436032 in patients (pts) with mIDH1 adv... von Wick, W., Tabatabai, G., Schuler, M., Rorhberg, K., Chawla, S.P., Janku, F., Schiff, D., Heinemann, V., Narita, Y., Ando, Y., Lenz, H.J., Ikeda, M., Genvresse, I., Rentzsch, C., Reschke, S., Cyris, C., Cai, C., Jeffers, M., Peña, C., Bähr, O.

Volltext